Trial for Bayer's Xarelto under scrutiny over defective device

BERLIN (Reuters) - European and U.S. drug regulators are looking into whether a defective blood-clotting test device affected a trial involving Bayer's blockbuster anti-blood clotting drug Xarelto, hitting the German drugmaker's shares.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro